Wedbush Upgrades Harpoon Therapeutics (HARP) to Outperform
Get Alerts HARP Hot Sheet
Price: $23.01 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Wedbush analyst Robert Driscoll upgraded Harpoon Therapeutics (NASDAQ: HARP) from Neutral to Outperform with a price target of $7.00 (from $5.00).
For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.
Shares of Harpoon Therapeutics closed at $2.00 yesterday.
You May Also Be Interested In
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR2,550 at BNP Paribas Exane
- Samsung Electronics Co Ltd. (005930:KS) (SSNLF) PT Raised to KRW530,000 at Citi
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share